Andrew R. Blight

2007

In 2007, Andrew R. Blight earned a total compensation of $1.5M as Chief Scientific Officer at Acorda Therapeutics, a 105% increase compared to previous year.

Compensation breakdown

Bonus$60,522
Option Awards$1,158,886
Salary$275,100
Other$6,750
Total$1,501,258

Blight received $1.2M in option awards, accounting for 77% of the total pay in 2007.

Blight also received $60.5K in bonus, $275.1K in salary and $6.8K in other compensation.

Rankings

In 2007, Andrew R. Blight's compensation ranked 2,974th out of 8,700 executives tracked by ExecPay. In other words, Blight earned more than 65.8% of executives.

ClassificationRankingPercentile
All
2,974
out of 8,700
66th
Division
Manufacturing
1,022
out of 3,314
69th
Major group
Chemicals And Allied Products
198
out of 746
74th
Industry group
Drugs
106
out of 546
81st
Industry
Biological Products, Except Diagnostic Substances
23
out of 118
81st
Source: SEC filing on April 27, 2010.

Blight's colleagues

We found four more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2007.

2007

Jane Wasman

Acorda Therapeutics

General Counsel

2007

David Lawrence

Acorda Therapeutics

Chief Financial Officer

2007

Mary Fisher

Acorda Therapeutics

Chief Operating Officer

2007

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

In-depth

You may also like